Cardiome Pharma (CRME) News Today → Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your Share (From Colonial Metals) (Ad) Free CRME Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share HeadlinesStock Analysis All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineAmphastar Pharmaceuticals (FRA:29A) Price Target Increased by 46.10% to 60.45nasdaq.com - August 13 at 8:50 PMExpert Analysis on Pharmaceutical Rubber Stoppers Market by 2023-2030marketwatch.com - March 25 at 7:37 AMGlenmark Pharmaceuticals receives 2nd ANDA tentative approval for Saxagliptin Tablets, 2.5 mg and 5 mgmsn.com - February 17 at 1:50 AMPharmacy Career Conference returned in its 4th edition to assist and inspire pharmacy students and industry professionalsmsn.com - February 12 at 4:32 AMPharma sector growth healthy after Covid toomsn.com - February 1 at 6:39 AMDOJ sues pharma giant AmerisourceBergen Corp. for allegedly helping to fuel the opioid epidemiccbsnews.com - December 29 at 3:02 PMAcute Coronary Syndrome Therapeutics Market Size in Pharma & Healthcare Sector is Growing Quickly with Analysis by Top Key players till 2028marketwatch.com - November 2 at 6:25 PMPharmaceutical Fine Chemicals Category Is Projected to Grow at a CAGR of 5.86% by 2026, SpendEdge Reportsyahoo.com - October 20 at 9:08 PMJenny Sundqvist new CEO of InDex Pharmaceuticalsfinance.yahoo.com - October 13 at 3:12 PM1SOMAÍ Pharmaceuticals Opens Medical Cannabis Manufacturing Facility In Portugalbenzinga.com - September 28 at 11:36 PMNLEM 2022 | Govt releases new list of 384 essential medicines; 34 drugs added, 26 droppedmsn.com - September 13 at 4:42 PMMacleods Pharmaceuticals defers big-bang listing plans; will PE funds step in now?msn.com - September 13 at 11:41 AMCardiac Rhythm Management Devices Market [4.5% CAGR] 2022 Industry Research Analysis Opportunities Key Players Analysis And Forecast By 2028marketwatch.com - August 30 at 6:44 PMCardiome Pharma Corp. Announces Approximately US$15.0 Million Bought Deal Financingfinance.yahoo.com - October 26 at 11:15 AM Get Cardiome Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for CRME and its competitors with MarketBeat's FREE daily newsletter. Email Address Elon to Transform U.S. Economy? (Ad)A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” grift of the elites. And yet, while it threatens their wealth and power, it could be transformational for both the U.S. economy and your wealth. One company holds a near-total monopoly on it. CRME Media Mentions By Week CRME Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CRME News Sentiment▼0.000.42▲Average Medical News Sentiment CRME News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CRME Articles This Week▼00▲CRME Articles Average Week Get Cardiome Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for CRME and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: CNTX News LVTX News MYNZ News NLSP News PHVS News PROC News QLI News TLSA News ACONW News DRTSW News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CRME) was last updated on 5/5/2024 by MarketBeat.com Staff From Our PartnersBiden to Launch “FedNOW” [Move Your Money Now]Priority GoldElon to Transform U.S. Economy? Porter & CompanyAutomatic Income (from home)Awesomely, LLCCould Your Accounts Be Frozen?Allegiance GoldThe asset beating inflation by 4xColonial MetalsUrgent Nvidia WarningAltimetryThe A.I. story nobody is telling you (Read ASAP)TradeSmithWarren Buffet Stockpiling Gold?Reagan Gold Group Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cardiome Pharma Corp Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
